Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind Clinical Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MK-1167 in Healthy Elderly Participants
Conditions
Interventions
MK-1167
Placebo
Locations
1
United States
California Clinical Trials Medical Group managed by PAREXEL-PAREXEL International (Site 0001)
Glendale, California, United States
Start Date
September 18, 2023
Primary Completion Date
May 8, 2024
Completion Date
May 8, 2024
Last Updated
October 3, 2024
NCT00104325
NCT07470866
NCT07388667
NCT07221448
NCT07118891
NCT03878121
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions